Solanbridge Group Inc Announces 500 Million Common Stock Share Reduction


HOUSTON, May 15, 2014 /PRNewswire/ — Solanbridge Group Inc (OTC: SLNX) is pleased to announce that on May 14, 2014, due to the commitment of Solanbridge to the medical marijuana industry, the Company has cancelled and retired another 500 million common stock shares of SLNX. Those shares will be returned to the Company’s Treasury immediately. This is the third promised share reduction of SLNX common stock—for a total cancellation and retirement of 1.5 billion common stock shares overall.

Solanbridge Group Inc crosses over to the marijuana sector, with a focus on CBD technology.


Repost is the designation for articles collected from the Internet whose content may interest our readers. These articles are not written by our staff and they do not necessarily reflect our views.

Related posts